SPRY:NASDAQ, ARS Pharmaceuticals, Inc.

SPRY stock overview

ARS Pharmaceuticals, Inc. (SPRY:NASDAQ) closed at $4.32 on October 22, 2026, up 3.35% on the day. The stock trades 67.1% below its 52-week high of $13.15 and 13.4% above its 52-week low of $3.81. Over the past year, it lost 55.2%. ARS Pharmaceuticals, Inc. is part of the Health Care sector.

Key figures

Price
$4.32
Day change
+3.35%
Volume
1,787,556
Average volume
1,756,317
Market cap
429M+
52-week range
$3.81 – $13.15
50-day average
$4.88
200-day average
$7.66

Price action over the past year

In 252 trading sessions since October 22, 2025, SPRY closed higher on 109 days (43%). Its best day was January 9, 2026 (+19.27%) and its worst was June 25, 2026 (-23.91%). The stock moved 10% or more in a single session 10 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

SPRY news

About ARS Pharmaceuticals, Inc.

Silverback Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on leveraging its ImmunoTAC technology platform to develop tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases.

Similar stocks

Find more stocks like SPRY with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.